Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 225 recruiting now early-phase tilt #2 of 28,963 conditions

Healthy: early-phase trial registry

225 of 1,096 indexed Healthy trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2 of 28,963 conditions by registered trial count.

1,096 US clinical trials · 225 currently recruiting · #2 of 28,963 conditions by registered trial count

Healthy: 1,096 US clinical trials tracked, 225 recruiting.

Healthy is the subject of 1,096 registered US clinical trials on ClinicalTrials.gov, 225 of them currently open to new participants. 43 are in Phase 3-4 (later-stage) and 546 in Phase 1-2 (earlier-stage). The most active sponsor is Eli Lilly and Company, running 55 of these trials.

Open enrollment, early-phase tilt

Healthy has 1,096 registered US clinical trials, 225 of them open to new participants right now, about 21% of the total.

225
recruiting participants now
21%
of trials open to enrollment
43
in Phase 3-4 (later-stage)
55
top sponsor: Eli Lilly and Company

Corpus placement: #2 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.

Key findings

What ClinicalTrials.gov does not surface for Healthy on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.

  1. Healthy is recruiting below its size-band peers.

    225 of 1,096 indexed trials (20.5%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Healthy trials is spread across many organizations.

    Eli Lilly and Company accounts for 55 of 1,096 trials (5%). 429 distinct sponsors appear on at least one study for this condition label.

  3. Most Healthy trials plan to enrol fewer than 100 people.

    Median target enrolment is 40 among the 1,091 trials that report a genuine target (sentinel values excluded). 851 of those (78%) plan for fewer than 100 participants.

  4. Healthy research is mostly interventional.

    905 interventional and 191 observational studies make up this index (82.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 1518Phase 228Phase 311Phase 432

Open and recent trials

1,096 total, page 4 of 22

RECRUITING NA 40 participants

Beneficial Exposome Study

Stanford University

NCT06093464

RECRUITING Phase 2 40 participants

A Nasal Treatment for COVID-19

Indiana University

NCT05799521

RECRUITING NA 40 participants

The Effect of Synaquell™ in Contact Sport Athletes

Mayo Clinic

NCT06104670

RECRUITING NA 40 participants

Neurofeedback to Reduce Spontaneous Recovery of Threat Expectancy

Trustees of Princeton University

NCT07122739

RECRUITING NA 40 participants

Experiment 2: One Target in Many Situations

Brigham and Women's Hospital

NCT06934148

RECRUITING 40 participants

Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease

Stanford University

NCT06215222

RECRUITING Phase 1 40 participants

A Study of LY4515100 in Healthy Participants

Eli Lilly and Company

NCT07339722

RECRUITING NA 40 participants

Multifocal HD-tDCS and Motor Function

University of Michigan

NCT06561165

RECRUITING Phase 4 40 participants

Effects of GH and Lirglutide on AgRP

Columbia University

NCT05681299

RECRUITING 40 participants

Predicting Future Errors During Skill Performance

National Institute of Neurological Disorders and Stroke (NINDS)

NCT06707207

RECRUITING NA 40 participants

Mixed Vs Blocked Search: Four Unique Tasks

Brigham and Women's Hospital

NCT06933693

RECRUITING Phase 1 40 participants

Assessment of 11C-JMJ-129 for Imaging PDE4D in Brain and Whole Body of Healthy Volunteers

National Institute of Mental Health (NIMH)

NCT06874205

RECRUITING NA 40 participants

A Randomized, Double Blind, Placebo Controlled, Clinical Study to Examine the Benefits of an Oral Product in Panelists With Menopausal Symptoms Including Vasomotor Symptoms (VMS).

Olly, PBC

NCT07033013

RECRUITING NA 38 participants

Effect of Sex on Orthostatic Intolerance and Cardiovascular Response During Lunar Descent and Ascent

National Aeronautics and Space Administration (NASA)

NCT06467825

RECRUITING Phase 1 36 participants

A Study to Explore the Effect of SP-624 on Brain Network Analytics in Healthy Adults and Adults With Major Depression

Sirtsei Pharmaceuticals

NCT06570369

RECRUITING NA 36 participants

Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers

University of Missouri-Columbia

NCT07220265

RECRUITING Phase 1 35 participants

A Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics of TIX100 in Healthy Subjects

TIXiMED

NCT06800729

RECRUITING NA 35 participants

Evaluation of the Potential of Grape Consumption to Improve Muscle Strength and Cognitive Function

Western New England University

NCT07208916

RECRUITING Phase 1 33 participants

A Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe Liver Function

Eli Lilly and Company

NCT06916078

RECRUITING NA 32 participants

Sodium vs Potassium Education to Improve Vascular Health

Florida State University

NCT07221448

RECRUITING Phase 1 32 participants

A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver Problems

Boehringer Ingelheim

NCT07023354

RECRUITING NA 32 participants

Neural Control of Kidney Blood Flow During Exercise in African American Adults

University of Massachusetts, Boston

NCT03981640

RECRUITING Phase 1 32 participants

Effect of Hepatic Impairment on the Pharmacokinetics of Mirdametinib

SpringWorks Therapeutics

NCT06997276

RECRUITING NA 32 participants

Dinner Time for Obesity and Prediabetes

Johns Hopkins University

NCT05745441

RECRUITING Phase 1 32 participants

A Study of IBI3032 in Healthy Participants

Fortvita Biologics (USA)

NCT07120425

RECRUITING NA 30 participants

ImmunoBoost: The Lymphatic Osteopathic Manipulative Treatment Protocol Study

Western University of Health Sciences

NCT06565065

RECRUITING 30 participants

Growth Hormone Resistance of Beta-cells

University of Missouri-Columbia

NCT06571487

RECRUITING NA 30 participants

A Study to Evaluate the Impact of Lactobacillus Rhamnosus GG on Proton Pump Inhibitor-Induced Gut Dysbiosis

Mayo Clinic

NCT05517928

RECRUITING NA 30 participants

Effect of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Plasma Insulin Levels

Indiana University

NCT06597149

RECRUITING Phase 1 30 participants

Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought

Johns Hopkins University

NCT05301608

RECRUITING NA 30 participants

Avocado and Postprandial Responses

University of Vermont Medical Center

NCT06818032

RECRUITING 30 participants

Growth Hormone Resistance of Beta-cells in Women and People

University of Missouri-Columbia

NCT06571500

RECRUITING 30 participants

RECOVERS - Realigning Emotion and COgnition Via prEcision Regulation networkS

Medical University of South Carolina

NCT05977439

RECRUITING NA 30 participants

Protein Requirements for Active Children

Arkansas Children's Hospital Research Institute

NCT04573439

RECRUITING NA 30 participants

A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule

Massachusetts General Hospital

NCT07219537

RECRUITING 30 participants

Relationship Between Great Toe Strength And Symptoms of Chemotherapy-Induced Peripheral Neuropathy (CIPN)

University of Florida

NCT07009717

RECRUITING NA 30 participants

tFUS Induced Transient Scotoma for Individual Dosing

Medical University of South Carolina

NCT06426498

RECRUITING Phase 4 30 participants

Endothelial Derived Hyperpolarization Factor and Vascular Control

University of Oklahoma

NCT05176379

RECRUITING 30 participants

Evaluation and Optimization of Ultrasound and/or MRI Hardware and Software

State University of New York - Upstate Medical University

NCT00640107

RECRUITING NA 30 participants

Airway Data Collection With the Entarik Feeding Tube System

Theranova, L.L.C.

NCT06760572

RECRUITING Phase 1 28 participants

A Clinical Trial in Healthy Participants to Learn How Itraconazole Affects MK-2828 Levels and How MK-2828 Affects Midazolam Levels (MK-2828-007)

Merck Sharp & Dohme

NCT07435194

RECRUITING Phase 1 28 participants

A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function

Pfizer

NCT07315360

RECRUITING Phase 1 26 participants

A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With and Without Reduced Liver Function

Pfizer

NCT07269301

RECRUITING NA 24 participants

Oxalate and Citrate in Humans - Response to Citrate

University of Chicago

NCT06944223

RECRUITING Phase 1 24 participants

Evaluate the Pharmacokinetics, Safety, and Tolerability of NSHO-101 in Healthy Participants

Ensho Therapeutics

NCT07403552

RECRUITING 24 participants

Ex Vivo Expansion (ACT-X)

Mayo Clinic

NCT07137312

RECRUITING Phase 1 24 participants

Alternation in the Human Microbiome With Commonly Used Topical Medications

University of California, Davis

NCT03437005

RECRUITING NA 24 participants

Adipose Tissue Blood Flow in Aging Humans

Mayo Clinic

NCT06096532

RECRUITING Phase 1 24 participants

A Study of the Effect of Diltiazem on the Plasma Levels of Nemtabrutinib (MK-1026-022)

Merck Sharp & Dohme

NCT07232589

RECRUITING Phase 1 24 participants

Study to Evaluate CAY001 in Healthy Volunteers

Cayuga Biotech

NCT06845839

← Previous Page 4 of 22 Next →

Phase Distribution

PhaseTrial count
Phase 1 518
Phase 2 28
Phase 3 11
Phase 4 32

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What is open for Healthy right now

225 recruiting of 1,096 indexed (21% open).

Phase mix: 43 late (III/IV) vs 546 early (I/II) (early-phase heavy).

Top sponsor: Eli Lilly and Company (55 trials), 9 others listed. 50 shown below, recruiting first. #2 of 28,963 conditions by registered trial count.

How open-enrollment share is computed

Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.

Frequently Asked Questions

How many clinical trials are there for Healthy?

PlainTrial tracks 1,096 US clinical trials for Healthy, of which 225 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Healthy?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.